Nicholas P Restifo
11PUBLICATIONS
43CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Jul 12, 2025
Regenerative Immunotherapy for Cancer: Transcription Factor Reprogramming of Tumor-Specific T Cells.Tyler R McCaw, Nicholas P Restifo, Kathrin Plath
|Apr 18, 2024
Synthetic soldiers: Turning T cells into immortal warriors.Nicholas P Restifo, Luca Gattinoni
|Jun 28, 2023
Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem Cells.S M Rafiqul Islam, Takuya Maeda, Naritaka Tamaoki
|Sep 16, 2021
An engineered IL-2 partial agonist promotes CD8+ T cell stemness.Fei Mo, Zhiya Yu, Peng Li
|Oct 20, 2019
Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation.Anthony L Schwartz, Pulak R Nath, Michael Allgauer
|Oct 09, 2019
Developing neoantigen-targeted T cell-based treatments for solid tumors.Tori N Yamamoto, Rigel J Kishton, Nicholas P Restifo
Pageof 2
Frequent Collaborators
3 joint publications
Ping-Hsien Lee
3 joint publications
Tori N Yamamoto
2 joint publications
Suman Kumar Vodnala
2 joint publications
Rigel J Kishton
1 joint publications
Ngoc-Han Ha
1 joint publications
MinHwa Shin
1 joint publications
Douglas C Palmer
1 joint publications
Xiaojing Liu
1 joint publications
Jason W Locasale
1 joint publications
Christopher A Klebanoff
